REBOA has been around since the 1950's, when first used by American Lt. Col. Carl W. Hughes during the Korean War. Although it's used globally for the management of severe non-compressible torso haemorrhage, the evidence base to date doesn't support such widespread adoption. Is it beneficial? Is it harmful? Join us at the Critical Care Reviews Meeting 2023 to hear the results of the first randomised controlled trial investigating this device - the UK REBOA Trial.
added March 21st
A supplemental Critical Care Reviews Newsletter, covering the major research published on March 21st at the Brussels International Symposium on Intensive Care & Emergency Medicine.
added March 21st
Need a trauma guideline? We have over 50 open access guidelines across a range of conditions relevant to critical care. If we're missing a major open access critical care airway guideline, please let us know.
Want to see the major cardiac arrest trials all in the one place? We have links to over 50 listed on our Major Resuscitation Trials page. If we're missing a major resuscitation trial, please let us know.
Our current list of critical care journals tops 108, including 57 open access journals. And we scan them all for our daily Journal Watch feature. It's the largest collection available for this specialty.
We follow the critical care literature daily so you don't have to. Either keep track of our Journal Watch webpage or register for our free weekly newsletter, containing links to all the papers posted in our journal watch resource over the previous week. There's nothing else like it.
Registration for the Critical Care Reviews Meeting 2023 opens on Monday, October 17th at 19:00 UTC+1. The meeting is being held in Titanic Belfast, Belfast, Northern Ireland. This niche meeting hosts major critical care trial results, reviews the best trials of the preceding 12 months and discusses all aspects of trial methodology, design, interpretation and publishing.